Continuing our women in STEM series, today we are spotlighting Joanna Robinson and what drives her passion for oncology research. 👉linkedin.com/feed/update/ur… #WomenInSTEM #Cancer #IWD2025 #InternationalDayOfWomenAndGirlsInScience

We’ve just released our financial results and Annual Report for 2024! 👉investors.molecularpartners.com/news-releases/… #Financials #FinancialResults #AR2024 #Oncology #Cancer #DARPin #RadioDARPin

We’re looking forward to presenting at the Fourth Transatlantic Exchange in Oncology, which takes place in Paris on Wednesday March 19. 👉events.medscapelive.org/website/82041/ #Investing #Conferences #Oncology #Cancer #DARPin #RadioDARPin

A big thank you to everyone who attended and engaged with us at the Fourth Transatlantic Exchange in Oncology this week – particularly around our presentation on scaling up the Radio-DARPin platform with Orano Med. #Investing #Conferences #Oncology #Cancer #DARPin #RadioDARPin

Join us in Chicago at the American Association for Cancer Research (AACR) Annual Meeting 2025, from April 25-30! 👉investors.molecularpartners.com/news-releases/… #Cancer #Oncology #AACR2025 #DARPin #RadioDARPin

Our CEO Patrick Amstutz will be taking part in a panel discussion on radiopharmaceuticals at the Van Lanschot Kempen Life Sciences Conference, on April 3 at 10:30am CET. #Cancer #Oncology #Biotech #Investing #DARPin #RadioDARPin

Molecular Partners’ exclusive strategic partnership with Orano Med on Radio-DARPins is particularly powerful. Find out more and look out for our upcoming presentation at #AACR2025. 👉 linkedin.com/posts/molecula… #Radiotherapy #RadioDARPins #NextGenMedicine #Biotech #Cancer

Our Radio-#DARPin platform delivers radioactive payloads directly to solid tumors. Don’t miss our presentation on targeting mesothelin (MSLN) at #AACR2025! 👉 linkedin.com/feed/update/ur… #Biotech #Innovation #Cancer #NextGenMedicine

Molecular Partners will be attending Swiss Biotech Day on May 6, 2025! We are a sponsor of this event, which is a fantastic opportunity to connect. 👉linkedin.com/feed/update/ur… #SwissBiotechDay #SBD2025 #Networking #Biotech #Conference #Investing #Radiotherapy #DARPin #RadioDARPin

We were delighted to welcome shareholders to our Annual General Meeting (AGM) today. All resolutions were approved. 👉lnkd.in/ead7jAYX #AGM2025 #Biotech #Innovation #ShareholderSupport #DARPin #RadioDARPin

On AML World Awareness Day, we stand united to shine a light on Acute Myeloid Leukemia (AML), a challenging and aggressive form of blood cancer.     👉 linkedin.com/posts/molecula…

The DARPin modality underpins our Switch-DARPin pipeline, through which we are opening doors to treat diseases with precision and efficiency. We presented on it at #AACR2025. investors.molecularpartners.com/scientific #Biotech #Innovation #Cancer #DARPin #NextGenMedicine

We had the pleasure of hosting 55 talented biotechnology students from ZHAW, who are exploring future career opportunities. linkedin.com/posts/molecula… #Biotech #Careers #Students #Innovation #DARPin #RadioDARPin

We have a lot going on today at Swiss Biotech Day! Check out the details below. #SwissBiotechDay #SBD2025 #Networking #Biotech #Conference #Investing #Radiotherapy #DARPin #RadioDARPin

We’re looking forward to hosting and participating in a panel discussion on Radioligand therapies at Swiss Biotech Day, on Tuesday May 6 at 15:00-15:45. 👉 linkedin.com/posts/molecula… #SwissBiotechDay #SBD2025 #Biotech #Conference #Investing #Radiotherapy #DARPin #RadioDARPin

Swiss Biotech Day 2025 was a great opportunity to connect with thought-leaders, partners, investors, media and other stakeholders and share insights. #SwissBiotechDay #SBD2025 #Biotech #Conference #Investing #Radiotherapy #DARPin #RadioDARPin linkedin.com/feed/update/ur…

We had the privilege to present not just once, but twice, at the 2025 PEGS Boston Summit. #PEGSBostonSummit #Biotech #DARPin #RadioDARPin #Innovation #Science linkedin.com/posts/molecula…

We had a great time this weekend taking part in the Sola Run Zurich! Our 14-member running team tackled a challenging 115 km course. #SOLAStafette #TeamSpirit #CommunityEngagement #CompanyPride #ZurichEvents #SwissSports linkedin.com/feed/update/ur…

We and our strategic partner Orano Med are pleased to announce the debut of MP0726, our Radio-DARPin candidate targeting mesothelin (MSLN) - and to present preclinical data at SNMMI tomorrow. #Cancer #Oncology #Radiotherapy #DARPin #RadioDARPin investors.molecularpartners.com/news-releases/…

We’ve been in Boston with the Venture Leaders Biotech teams - a selection of the most promising Swiss based biotech startups attending a global business development and investor roadshow. #Cancer #Oncology #Radiotherapy #DARPin #RadioDARPin #Investing linkedin.com/feed/update/ur…